Tryptamine Therapeutics Limited (ASX:TYP)
Australia
· Delayed Price · Currency is AUD Tryptamine Therapeutics Statistics
Total Valuation
ASX:TYP has a market cap or net worth of AUD 43.17 million. The enterprise value is 40.35 million.
| Market Cap | 43.17M |
| Enterprise Value | 40.35M |
Important Dates
The next estimated earnings date is Tuesday, September 30, 2025.
| Earnings Date | Sep 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:TYP has 1.44 billion shares outstanding. The number of shares has increased by 460.94% in one year.
| Current Share Class | 1.44B |
| Shares Outstanding | 1.44B |
| Shares Change (YoY) | +460.94% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 32.21% |
| Owned by Institutions (%) | 2.78% |
| Float | 877.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.52 |
| PB Ratio | 7.68 |
| P/TBV Ratio | 8.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.47 |
| EV / Sales | 30.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.87, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.87 |
| Quick Ratio | 3.69 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.15 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -82.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +45.00% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 39.91 |
| Average Volume (20 Days) | 1,217,227 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:TYP had revenue of AUD 1.33 million and -7.37 million in losses. Loss per share was -0.01.
| Revenue | 1.33M |
| Gross Profit | -1.02M |
| Operating Income | -4.63M |
| Pretax Income | -7.37M |
| Net Income | -7.37M |
| EBITDA | -4.62M |
| EBIT | -4.63M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 5.37 million in cash and 199,180 in debt, giving a net cash position of 5.17 million or 0.00 per share.
| Cash & Cash Equivalents | 5.37M |
| Total Debt | 199,180 |
| Net Cash | 5.17M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 5.62M |
| Book Value Per Share | 0.00 |
| Working Capital | 5.25M |
Cash Flow
| Operating Cash Flow | -7.20M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -76.85% |
| Operating Margin | -349.01% |
| Pretax Margin | -555.37% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:TYP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -460.94% |
| Shareholder Yield | n/a |
| Earnings Yield | -17.08% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:TYP has an Altman Z-Score of 3.52 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.52 |
| Piotroski F-Score | 2 |